Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks ResignsInvestors Business Daily • 03/31/25
Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older AdultsAccesswire • 03/31/25
Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • 03/21/25
Is Moderna Stock A Sell As RFK Jr. Reportedly Mulls A Massive Funding Pull?Investors Business Daily • 03/20/25
Moderna Stock Trades Near 52-Week Low: Should You Buy, Hold or Sell?Zacks Investment Research • 03/18/25
Moderna (MRNA) Presents at Barclays 27th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 03/11/25
The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron PharmaceuticalsZacks Investment Research • 03/07/25
Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & MoreZacks Investment Research • 03/06/25
S&P 500 Gains and Losses Today: Moderna Stock Pops as Execs Buy Shares, Express Cancer Vaccine OptimismInvestopedia • 03/05/25